ShirleyKSawaiMD

Maternal & Fetal Medicine/High Risk

Valley Perinatal Services

Dr. Sawai is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
35 Hope Drive
Ste 202204
Hershey, PA 17033
Phone+1 717-531-3503

Fax+1 717-531-4375

Dr. Shirley Sawai is a Maternal Fetal Medicine specialist in Phoenix, AZ and is affiliated with multiple hospitals in the area, as well as WellSpan York Hospital and University of Missouri Womens and Valley Childrens Hospital in Madera, CA and Memorial Hospital of South Bend. She received her medical degree and residency and fellowship training from University of South Florida Morsani College of Medicine and has been in practice 32 years. She specializes in maternal & fetal medicine/high risk and is experienced in general obstetrics, maternal and fetal medicine, medical management of high-risk pregnancies with interests in diabetes, preterm labor prevention, preeclampsia prevention, cervical insufficiency, diagnostic ultrasound, and prenatal diagnosis. She has 9 publications and over 200 citings.

University of South Florida MorsaniFellowship, Maternal-Fetal Medicine, 1989 - 1991
University of South Florida MorsaniResidency, Obstetrics and Gynecology, 1985 - 1989
University of South Florida College of MedicineClass of 1985

PubMed

19 citations
Removal versus retention of cerclage in preterm premature rupture of membranes: a randomized controlled trial
Anna M Galyean, Thomas J. Garite, Kimberly Maurel, Diana Abril, Charles Adair
American Journal of Obstetrics and Gynecology. 2014-10-01
26 citations
Pre-induction cervical ripening: a randomized comparison of two methods.
Judith Krammer, Mark C. Williams, Shirley K. Sawai, William F. O'Brien
Obstetrics and Gynecology. 1995-04-01
38 citations
Patient-administered outpatient intravaginal prostaglandin E2 suppositories in post-date pregnancies: a double-blind, randomized, placebo-controlled study
Shirley K. Sawai, William F. O'Brien, Dimitrios Mastrogiannis, Judith Krammer, Micheal G. Mastry
Obstetrics and Gynecology. 1994-11-01

Journal Articles

Antenatal thyrotropin-releasing hormone to prevent lung disease in preterm lung disease in preterm infants.
Ballard RA, Ballard PL, Canaan A, Pinto-Martin J, David D, Padbury JF, Phibbs RH, Daner JT, Hart MC, Mannino FL, Sawai S:K, N Engl J Med 1998;338: 493-8, 1998